Inovio reports first quarter 2021 financial results

Plymouth meeting, pa., may 10, 2021 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on rapidly bringing to market precisely designed dna medicines to treat and protect people from infectious diseases, cancer, and hpv-associated diseases, today reported financial results for the quarter ended march 31, 2021.

INO Ratings Summary

INO Quant Ranking